1. Home
  2. CYAB vs BFRG Comparison

CYAB vs BFRG Comparison

Compare CYAB & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CYAB

Cyabra Inc. Common Stock

N/A

Current Price

$0.51

Market Cap

7.5M

Sector

N/A

ML Signal

N/A

Logo Bullfrog AI Holdings Inc.

BFRG

Bullfrog AI Holdings Inc.

HOLD

Current Price

$0.72

Market Cap

6.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYAB
BFRG
Founded
2017
2017
Country
United States
United States
Employees
N/A
17
Industry
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
6.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CYAB
BFRG
Price
$0.51
$0.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
210.5K
280.3K
Earning Date
04-09-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$0.43
52 Week High
$2.99
$2.04

Technical Indicators

Market Signals
Indicator
CYAB
BFRG
Relative Strength Index (RSI) 32.34 53.00
Support Level $0.46 $0.65
Resistance Level $0.62 $0.82
Average True Range (ATR) 0.06 0.07
MACD 0.02 0.01
Stochastic Oscillator 19.81 77.88

Price Performance

Historical Comparison
CYAB
BFRG

About CYAB Cyabra Inc. Common Stock

Cyabra Inc is an AI-powered SaaS company that detects and analyzes online disinformation. Its platform uses machine learning to monitor social media and news data in real time, identify fake accounts and harmful narratives, and assess content authenticity and sentiment.

About BFRG Bullfrog AI Holdings Inc.

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.

Share on Social Networks: